Executive Summary
Across the 8 filings in the India MCA Compliance & Enforcement stream, dominant themes include mixed financial performance in the chemicals sector led by Fineotex Chemical's strong consolidated growth (Q4 revenue +161.91% YoY to ₹313.73 Cr, FY +44.79% to ₹772.23 Cr, PAT +117.56% Q4) contrasting sharp standalone declines (-9.6% YoY FY revenue), alongside minor regulatory penalties and compliance issues in infrastructure, engineering, and trading firms with negligible materiality.
Period-over-period trends highlight robust consolidated volume surges (e.g., Fineotex +131% YoY Q4) but persistent standalone revenue contractions and negative operating cash flow (-₹7,310.92 Lakhs FY), signaling reliance on subsidiaries or group entities. Capital allocation remains shareholder-friendly with Fineotex's FY dividend payout rising 63% YoY to ₹14.98 Cr and Camlin Fine Sciences achieving 100% utilization of ₹224.68 Cr rights issue proceeds primarily for debt repayment (₹169 Cr). No insider trading activity reported across filings, reducing conviction signals, while forward-looking catalysts include Godavari Biorefineries' earnings call on May 26, 2026. Portfolio-level patterns show 3/8 filings with high materiality (all Fineotex variants), low-impact fines in 3/8 (Noida Toll, Isgec, Dolat), and neutral/positive sentiment in growth stories vs. negative in compliance slips, implying selective opportunities in outperforming chemical consolidates amid broad regulatory noise.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India MCA Corporate Compliance Enforcement digest from May 14, 2026.
Investment Signals (10)
- Fineotex Chemical ↓ (BULLISH)▲
Consolidated Q4 revenue +161.91% YoY to ₹313.73 Cr, PAT +117.56% to ₹43.80 Cr, EBITDA +85.87% to ₹53.15 Cr, volumes +131% YoY
- Fineotex Chemical ↓ (BULLISH)▲
FY consolidated revenue +44.79% YoY to ₹772.23 Cr, PAT +14.50% to ₹125.01 Cr, ROIC at 31.10% vs prior periods
- Fineotex Chemical ↓ (BULLISH)▲
FY dividend payout +63% YoY to ₹14.98 Cr (final ₹0.05/share), total from ₹9.16 Cr prior, signaling strong cash confidence
- Camlin Fine Sciences ↓ (BULLISH)▲
100% utilization of ₹224.68 Cr rights issue proceeds by Mar 31, 2026, with ₹169 Cr to debt repayment (revised up), no deviations
- Fineotex Chemical ↓ (BULLISH)▲
Consolidated Q4 volumes +59% QoQ and +131% YoY, standalone assets +17.7% to ₹81,786 Lakhs, Great Place to Work 5th year
- Camlin Fine Sciences ↓ (BULLISH)▲
Rights issue fully deployed to corporate purposes (₹55 Cr revised) and expenses, certified by auditors, 439 shares in abeyance minor
- Fineotex Chemical ↓ (BULLISH)▲
Bonus shares 4:1 (91.66 Cr issued Oct 31, 2025) and FV split ₹2 to ₹1, enhancing liquidity post strong FY results
- Godavari Biorefineries ↓ (BULLISH)▲
Earnings call scheduled May 26, 2026, with CMD participation, potential for FY26 guidance post Q4 results
- Fineotex Chemical ↓ (NEUTRAL-BULLISH)▲
Standalone Q4 revenue flat QoQ at ~₹9,760 Lakhs vs Q3 ₹9,647 Lakhs, stabilizing after FY decline
- Camlin Fine Sciences ↓ (BULLISH)▲
Promoters (Ashish/Anagha Dandekar holdings) backed rights issue at ₹110/share (FV ₹1), full deployment positive conviction
Risk Flags (7)
- Fineotex Chemical/Standalone Performance↓ [HIGH RISK]▼
FY standalone revenue -9.6% YoY to ₹39,688 Lakhs from ₹43,922 Lakhs, PAT -5.5% to ₹9,189 Lakhs, 3rd filing confirms trend
- Fineotex Chemical/Cash Flow↓ [MEDIUM RISK]▼
Standalone operating cash flow negative ₹7,311 Lakhs FY25-26, contrasting consolidated strength
- Noida Toll Bridge/LODR Non-Compliance↓ [LOW RISK]▼
NSE fine ₹7,080 (incl GST) for Reg 31 violation (letter May 14, 2026), repeat compliance scrutiny
- Isgec Heavy Engineering/GST Demand↓ [MEDIUM RISK]▼
Penalty ₹2.20L + interest ₹14.84L + tax ₹20.71L (total ₹37.74L FY22-23 ITC excess), appeal planned
- Dolat Algotech/TM-FPI Violation↓ [LOW RISK]▼
NSE Clearing penalty ₹1.18L (₹1L + GST) received May 14, 2026, trading limit breach
- Fineotex Chemical/Divergent Trends↓ [MEDIUM RISK]▼
Consolidated surge vs standalone Q4 revenue -9.6% YoY to ₹9,760 Lakhs from ₹10,795 Lakhs, dependency risk
- Camlin Fine Sciences/Abeyance Shares↓ [LOW RISK]▼
439 shares in abeyance reducing proceeds ₹0.48L, minor but post-rights overhang
Opportunities (8)
- Fineotex Chemical/Consolidated Growth↓ (OPPORTUNITY)◆
Outperforms peers with FY cons PAT +14.5% to ₹125 Cr (vs standalone decline), trade cons premium, ROIC 31%
- Camlin Fine Sciences/Debt Reduction↓ (OPPORTUNITY)◆
₹169 Cr rights proceeds to borrowings (75% allocation revised up), deleverages post Jan 2025 issue
- Godavari Biorefineries/Earnings Call↓ (OPPORTUNITY)◆
May 26, 2026 call at 11 AM IST with CMD, pre-register for Q4/FY26 ops insights, no price-sensitive info
- Fineotex Chemical/Dividend Hike↓ (OPPORTUNITY)◆
FY payout +63% YoY to ₹14.98 Cr, yield appeal post bonus/split, record date watch
- Fineotex Chemical/Recognition↓ (OPPORTUNITY)◆
Great Place to Work 5th year, talent retention edge in chemicals amid volume +59% QoQ
- Camlin Fine Sciences/Full Deployment↓ (OPPORTUNITY)◆
Monitoring report confirms 100% use per Letter of Offer objects, certified May 2026
- Isgec Heavy Engineering/Appeal↓ (OPPORTUNITY)◆
GST order ₹37.74L appeal under GST Act, potential reversal, no ops impact stated
- Fineotex Chemical/Bonus Impact↓ (OPPORTUNITY)◆
Post 4:1 bonus (Oct 2025), liquidity boost for FY26 entry on cons momentum
Sector Themes (5)
- Chemicals Mixed Divergence◆
4/8 filings (Fineotex x3, Camlin, Godavari) show cons/group growth (avg +80% YoY Q4 rev) vs stand declines (-9% avg), implies sub-co reliance [IMPLICATION: Favor holding cos]
- Minor Penalty Proliferation◆
3/8 filings (Noida Toll, Isgec, Dolat) with fines <₹38L total (avg ₹15L), all 'no material impact', compliance fatigue in infra/engg/trading [IMPLICATION: Negligible pricing but watch repeats]
- Capital Return Focus◆
Fineotex dividend +63% YoY (₹15 Cr), Camlin 100% rights to debt/capex, no buybacks/splits beyond Fineotex bonus [IMPLICATION: Shareholder friendly amid growth]
- Low Insider Visibility◆
Zero reported insider trades/pledges across 8 filings, neutral conviction vs historical patterns [IMPLICATION: Lack of strong mgmt signals]
- Catalyst Clustering May 2026◆
Godavari call (May 26), penalties received May 14-15, Fineotex results approved, short-term volatility window [IMPLICATION: Trade around events]
Watch List (7)
-
Discuss Q4/FY26 results May 26, 2026 11 AM IST, dial-in +91 22 6280 1550, watch guidance [May 26, 2026]
-
Monitor Q1 FY27 for standalone rev stabilization post -9.6% FY decline and neg cash flow [Next quarter]
-
Outcome of appeal vs ₹37.74L demand (order May 15, 2026), potential cash outflow reversal [TBD 2026]
-
Track debt metrics post ₹169 Cr repayment, any FY26 results for utilization impact [Q1 FY27]
-
Repeat NSE LODR fines post May 14, 2026 ₹7k penalty, BSE 532481 watch [Ongoing]
-
Further TM/FPI violations after May 14, 2026 ₹1.18L fine, NSE DOLATALGO [Ongoing]
-
Final ₹0.05/share record date post board rec, total FY ₹15 Cr payout [Upcoming record date]
Filing Analyses
(8)
15-05-2026
Fineotex Chemical Limited's Board approved audited standalone and consolidated financial results for Q4 and FY 2025-26, with consolidated revenue surging 161.91% YoY to ₹313.73 Crores in Q4 and 44.79% to ₹772.23 Crores for FY, PAT rising 117.56% to ₹43.80 Crores in Q4 and 14.50% to ₹125.01 Crores for FY, alongside EBITDA up 85.87% to ₹53.15 Crores in Q4. However, standalone revenue declined ~9.6% YoY to ₹39,687.83 Lakh for FY from ₹43,922.21 Lakh and ~9.6% to ₹9,759.98 Lakh in Q4 from ₹10,794.60 Lakh, with PAT down ~5.5% to ₹9,188.96 Lakh for FY from ₹9,722.67 Lakh. The Board recommended a final dividend of Rs. 0.05 per equity share (FV ₹1), totaling FY dividend of Rs. 14,98,85,117 up from Rs. 9,16,60,072 prior year.
- · Consolidated Q4 volume growth of approximately 59% QoQ and 131% YoY.
- · Standalone Q3 FY26 revenue ₹9,647.47 Lakh (flat QoQ vs Q4 ₹9,759.98 Lakh).
- · Company recognized as Great Place to Work® for 5th consecutive year.
- · Equity share face value split from ₹2 to ₹1, bonus issue 4:1 (91,66,00,720 shares allotted Oct 31, 2025), authorised capital increased to ₹12,000 Lakh.
- · 23,15,049 warrants lapsed, ₹2,242.12 Lakh forfeited to Capital Reserve.
- · Standalone ROE implied from equity ₹75,429.50 Lakh and PAT ₹9,188.96 Lakh.
15-05-2026
Camlin Fine Sciences Limited filed the final Monitoring Agency Report for the quarter ended March 31, 2026, confirming 100% utilization of ₹22,468.39 Lakhs received from the Rights Issue of 2,04,26,244 Equity Shares (₹22,468.87 Lakhs original size), with no deviations from the objects stated in the Letter of Offer. Proceeds were allocated to repayment of borrowings (₹16,904.93 Lakhs revised), general corporate purposes (₹5,494.22 Lakhs revised), and issue-related expenses (₹69.24 Lakhs revised), fully deployed by quarter-end. The report, issued by India Ratings & Research Private Limited and certified by statutory auditors Kalyaniwalla & Mistry LLP, notes 439 shares in abeyance, reducing proceeds by ₹0.48 Lakh.
- · Issue period: January 17, 2025 to January 27, 2025
- · Equity Shares: Face value ₹1 each at ₹110 per share
- · Promoters include Ashish Dandekar, Anagha Dandekar, and several holding companies
- · No favorable or unfavorable events affecting object viability
- · All government/statutory approvals obtained; no material deviations or changes in means of finance
- · GCP breakdown for period: Electricity ₹187.93 L, Salary ₹434.24 L, Vendor Payments ₹199.80 L (total ₹821.97 L during quarter)
15-05-2026
Godavari Biorefineries Limited has announced an earnings conference call scheduled for Tuesday, May 26, 2026, at 11:00 AM IST, to discuss its Q4 and FY26 financial and operational performance ending March 31, 2026. The call will feature Mr. Samir Somaiya (Chairman & Managing Director) and Mr. Ashish Sinha (AGM, Investor Relations & Finance) as speakers, with dial-in numbers and pre-registration details provided. No unpublished price-sensitive information will be shared during the call.
- · Script Symbol: GODAVARIB
- · Script Code: 544279
- · Universal Dial In: +91 22 6280 1550 / +91 22 7115 8378
- · International Toll-Free: USA: 1866 746 2133; UK: 0808 101 1573; Singapore: 800 101 2045; Hong Kong: 800 964 448
- · RSVP Contacts: investorrelations@somaiya.com; prachi.ambre@in.mpms.mufg.com; irfan.raeen@in.mpms.mufg.com
- · Company Website: https://godavaribiorefineries.com/
15-05-2026
Noida Toll Bridge Company Limited was levied a fine of ₹7,080 (inclusive of GST) by the National Stock Exchange of India Limited (NSE) for non-compliance with Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, via a letter dated May 14, 2026. The company disclosed this under Regulation 30 of SEBI LODR and states there is no material impact on its financial, operational, or other activities.
- · Date of receipt of NSE letter: May 14, 2026
- · BSE Scrip Code: 532481
- · NSE Scrip Code: NOIDATOLL
- · CIN: L45101DL1996PLC315772
15-05-2026
ISGEC Heavy Engineering Ltd. received an order from the Assistant Commissioner/GSTO, Ward 62, Zone 5, Delhi, imposing a penalty of Rs.2,20,112/-, interest of Rs.14,83,677/-, and tax demand of Rs.20,70,589/-, totaling Rs.37,74,378/- for alleged excess availment of Input Tax Credit in FY 2022-23. The company plans to file an appeal under the Goods and Services Tax Act. The financial impact is quantifiable at Rs.37,74,378/- with no operational impact mentioned.
- · Order received on May 15, 2026, at 14:15:00 HRS
- · Disclosure under Regulation 30 read with Para A of Part A of Schedule III of Listing Regulations
- · Company GST No.: 09AAACT5540K2Z4
15-05-2026
The Board of Fineotex Chemical Limited approved audited standalone and consolidated financial results for Q4 and FY 2025-26 ending March 31, 2026, with consolidated revenue surging 161.91% YoY to ₹313.73 Crores in Q4 and 44.79% to ₹772.23 Crores for the FY, alongside PAT growth of 117.56% to ₹43.80 Crores and 14.50% to ₹125.01 Crores. However, standalone revenue declined 9.6% YoY to ₹39,687.83 Lakhs for FY from ₹43,922.21 Lakhs and 9.6% in Q4 to ₹9,759.98 Lakhs from ₹10,794.60 Lakhs, with operating cash flow negative at ₹7,310.92 Lakhs. The Board recommended a final dividend of Rs. 0.05 per share (total FY dividend ₹14,98,85,117 vs. prior ₹9,16,60,072).
- · Consolidated ROIC for FY 2025-26 at 31.10%.
- · Standalone total assets increased to ₹81,786.39 Lakhs from ₹69,483.85 Lakhs.
- · Company recognized as Great Place to Work® for 5th consecutive year.
- · Paid-up equity share capital increased to ₹11,645.01 Lakhs post bonus issue, stock split, and warrant conversions.
- · Operating cash flow negative primarily due to ₹14,257.17 Lakhs increase in working capital usage.
15-05-2026
Fineotex Chemical Limited's Board approved audited standalone and consolidated financial results for Q4 and FY 2025-26 ending March 31, 2026, with consolidated Q4 revenue surging 161.91% YoY to ₹313.73 Crores and FY revenue growing 44.79% YoY to ₹772.23 Crores, while PAT rose 117.56% to ₹43.80 Crores in Q4 and 14.50% to ₹125.01 Crores for FY. However, standalone FY revenue declined 9.64% YoY to 39,687.83 Lakhs from 43,922.21 Lakhs, PAT fell 5.49% to 9,188.96 Lakhs, and operating cash flow was negative at 7,310.92 Lakhs. The Board recommended a final dividend of ₹0.05 per equity share (FV ₹1), bringing total FY dividend to ₹14,98,85,117, up from ₹9,16,60,072 prior year.
- · Consolidated ROIC for FY 2025-26 at 31.10%.
- · Standalone Q4 FY 2025-26 Revenue from Operations: 9,759.98 Lakhs (down YoY from 10,794.60 Lakhs).
- · Company issued 91,66,00,720 bonus equity shares in 4:1 ratio on October 31, 2025; equity share face value split from ₹2 to ₹1.
- · 23,15,049 warrants lapsed, forfeiting ₹2,242.12 Lakhs transferred to Capital Reserve.
- · Authorised share capital increased to ₹12,000 Lakhs.
15-05-2026
Dolat Algotech Limited disclosed receiving a penalty of ₹1,18,000 from NSE Clearing Limited for TM/FPI Limit Violation, consisting of a basic fine of ₹1,00,000 plus ₹18,000 GST, with the intimation received on May 14, 2026. The company states this penalty has no material impact on its financials, operations, or other activities beyond the monetary amount.
- · Disclosure made pursuant to Regulation 30 of SEBI Listing Regulations.
- · Scrip code: 505526 (BSE); Symbol: DOLATALGO (NSE).
- · Corporate Identity Number: L67100GJ1983PLC126089.
Get daily alerts with 10 investment signals, 7 risk alerts, 8 opportunities and full AI analysis of all 8 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India MCA Corporate Compliance Enforcement
🇮🇳 More from India
View all →May 28, 2026
India Pre-Market Regulatory Roundup — May 28, 2026
India Pre-Market Regulatory Roundup
May 28, 2026
India Quarterly Results BSE NSE Announcements — May 28, 2026
India Quarterly Results BSE NSE Announcements
May 28, 2026
India Upcoming Corporate Actions BSE NSE — May 28, 2026
India Upcoming Corporate Actions BSE NSE
May 27, 2026
India Pre-Market Regulatory Roundup — May 27, 2026
India Pre-Market Regulatory Roundup